Literature DB >> 30394575

Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.

Ala I Sharara1, Luma Basma O Rustom1, Majd Marrache1, Hussein H Rimmani1, Halim Bou Daher1, Suzanne Koussa2, Ali Taher3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30394575     DOI： 10.1002/ajh.25339

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  Treatment of Chronic HCV Infection in Patients With Thalassemia.

Authors:  Halim Bou Daher; Ala I Sharara
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-01-29

2.  Thalassemia and hepatocellular carcinoma: links and risks.

Authors:  Maria Marsella; Paolo Ricchi
Journal:  J Blood Med       Date:  2019-09-17

Review 3.  Hepatitis C virus: A critical approach to who really needs treatment.

Authors:  Elias Kouroumalis; Argyro Voumvouraki
Journal:  World J Hepatol       Date:  2022-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.